These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2883201)

  • 41. The measurement of schizophrenic conceptualization using a Spanish translation of the Whitaker Index of Schizophrenic Thinking.
    Acevedo Noriega N; Gonzales MA; Puente AE; Whitaker LC
    J Clin Psychol; 1985 Mar; 41(2):157-61. PubMed ID: 3980738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects.
    Rao ML; Gross G; Strebel B; Bräunig P; Huber G; Klosterkötter J
    Psychiatry Res; 1990 Dec; 34(3):243-57. PubMed ID: 1981623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medication, logic, and schizophernic thinking: a reply to Marini.
    Ho DY
    J Genet Psychol; 1976 Sep; 129(1st Half):93-5. PubMed ID: 9471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased urinary peptide excretion in schizophrenic patients after neuroleptic treatment.
    Reichelt KL; Teigland-Gjerstad B
    Psychiatry Res; 1995 Sep; 58(2):171-6. PubMed ID: 8570770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.
    Glovinsky D; Kalogeras KT; Kirch DG; Suddath R; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):273-6. PubMed ID: 7910756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients.
    Troisi A; Pasini A; de Angelis F; Spalletta G
    J Clin Psychopharmacol; 1997 Apr; 17(2):84-7. PubMed ID: 10950468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered interleukin-3 serum levels in drug-naïve and neuroleptic-treated schizophrenic patients.
    Xiu MH; Chen S; Wang F; Cao LY; Qi LY; Chen DC; Wu GY; Lu L; Kosten TA; Kosten TR; Zhang XY
    Schizophr Res; 2008 Dec; 106(2-3):369-70. PubMed ID: 18838250
    [No Abstract]   [Full Text] [Related]  

  • 48. Kinesthetic figural aftereffects in acute schizophrenia: a style of processing stimuli.
    Kuster G; Harrow M; Tucker G
    Percept Mot Skills; 1975 Oct; 41(2):451-8. PubMed ID: 241970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treating acute schizophrenic illnesses.
    Livingston M
    Practitioner; 1989 Feb; 233(1463):244-6. PubMed ID: 2573896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects.
    Oke AF; Putz C; Adams RN; Bird ED
    Psychiatry Res; 1992 Dec; 45(4):203-8. PubMed ID: 1363335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia.
    Xu HM; Wei J; Hemmings GP
    Br J Psychiatry; 1994 Feb; 164(2):251-3. PubMed ID: 7909714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Religiosity, schizotypal thinking, and schizophrenia.
    Feldman J; Rust J
    Psychol Rep; 1989 Oct; 65(2):587-93. PubMed ID: 2798675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Addition of lithium to neuroleptic treatment in chronic schizophrenia.
    Lewis HA; Bacher NM; Field PB
    Am J Psychiatry; 1986 Feb; 143(2):262. PubMed ID: 2868667
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of antipsychotic medication on the linguistic ability of schizophrenics.
    Hymowitz P; Spohn H
    J Nerv Ment Dis; 1980 May; 168(5):287-96. PubMed ID: 6102593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On Ho's "modern logic and schizophrenic thinking".
    Marini JL
    J Genet Psychol; 1976 Sep; 129(1st Half):89-91. PubMed ID: 9470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of the Whitaker Index of Schizophrenic Thinking to a non-english-speaking population.
    Yaroush RA
    J Clin Psychol; 1982 Apr; 38(2):244-52. PubMed ID: 7068857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity.
    Hogan TP; Awad AG; Eastwood R
    Psychol Med; 1983 Feb; 13(1):177-83. PubMed ID: 6133297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug therapy in schizophrenia--variability of outcome and prediction of response.
    Awad AG
    Can J Psychiatry; 1989 Oct; 34(7):711-20. PubMed ID: 2572318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients.
    Mortensen PB
    Acta Psychiatr Scand; 1992 May; 85(5):390-3. PubMed ID: 1351334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum immunoglobulin levels in Chinese male schizophrenics.
    Chong-Thim W; Wing-Foo T; Nilmani S
    Schizophr Res; 1993 Jun; 10(1):61-6. PubMed ID: 8103669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.